Michael Healy-Rae
Ceist:804. Deputy Michael Healy-Rae asked the Minister for Health if she will review the case of a person (details supplied); and if she will make a statement on the matter. [13936/25]
Amharc ar fhreagraWritten Answers Nos. 804-813
804. Deputy Michael Healy-Rae asked the Minister for Health if she will review the case of a person (details supplied); and if she will make a statement on the matter. [13936/25]
Amharc ar fhreagraAs this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
805. Deputy Aindrias Moynihan asked the Minister for Health the number of clinical and support staff assigned to CAMHS in each of the CHO areas, in tabular form; and if she will make a statement on the matter. [13937/25]
Amharc ar fhreagra806. Deputy Aindrias Moynihan asked the Minister for Health the number of people in each CHO area who are waiting on initial CAMHS services, for zero to six months, six to 12 months 12 to 18 months and 18-plus months, in tabular form; and if she will make a statement on the matter. [13938/25]
Amharc ar fhreagraI propose to take Questions Nos. 805 and 806 together.
As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly as soon as possible.
807. Deputy Ivana Bacik asked the Minister for Health for a statement on the Baggot Street Hospital; for a statement on the registration of the site on the Intra-State Register for disposal by the HSE; and if she will report on her engagement with the HSE in respect of same. [13947/25]
Amharc ar fhreagraAs this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
808. Deputy Seán Fleming asked the Minister for Health when an invoice will be paid under the treatment abroad scheme as it is part of the essential comprehensive aftercare support that is required in relation to a person (details supplied); and if she will make a statement on the matter. [13949/25]
Amharc ar fhreagraAs this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
809. Deputy Richard O'Donoghue asked the Minister for Health further to Parliamentary Question No. 335 of 26 February 2025, whether the recent advice received from the HSE aligns with the response given to Parliamentary Question No. 735 of 30 April 2024, which identified the World Health Organisation's 2018 recommendation as the appropriate guidance for wind turbine noise; and if she will make a statement on the matter. [13954/25]
Amharc ar fhreagraFurther to Parliamentary Questions relating to the national position on wind turbine noise and shadow flicker from a health perspective, Parliamentary Question No. 335 of 26 February 2025 noted the HSE advice which hasn’t changed since the response given to PQ No. 735 of 30th April 2024.
810. Deputy Danny Healy-Rae asked the Minister for Health if the case of a person (details supplied) will be reviewed; and if she will make a statement on the matter. [13960/25]
Amharc ar fhreagraAs this is an operational matter, I have asked the Health Service Executive to respond directly to the Deputy as soon as possible.
811. Deputy Ken O'Flynn asked the Minister for Health to provide clarification regarding the rollout of free hormone replacement treatment for all women, which was due to be implemented in January 2025 (details supplied). [13965/25]
Amharc ar fhreagraMenopause is an important health and wellbeing issue affecting many women in Ireland. Much important work has been done to expand awareness and treatment in this area, driven by the Women’s Health Taskforce and the Women’s Health Action Plans.The Programme for Government: Securing Ireland’s Future continues to emphasise this important commitment to improving women’s health outcomes and experiences. It also commits to make HRT medicines available at no cost for the drug/product.
Budget 2025 announced the intention to fund the cost of HRT products prescribed to women to help manage the symptoms associated with all stages of menopause. This new HRT measure represents another step to widen access to and reduce costs associated with menopause related treatments and services and follows on from all the other developments that have taken place over several years. Legislation was passed in 2024 to enable the introduction of this new measure. It means that where a woman has been prescribed a HRT product by her healthcare provider to alleviate the symptoms associated with all stages of menopause, the cost of the HRT medications or products will be met by the State. For the purpose of this measure, menopause means, in relation to a woman, the various stages for the treatment of menopause symptoms and includes perimenopause, post menopause, early menopause, premature menopause and medically induced menopause. This measure will cover HRT medications and products which are reimbursable by the HSE, which have been prescribed for the purposes of alleviating the symptoms of menopause. Reimbursement support for this new measure will be available to participating pharmacies from the date of commencement.
It should also be noted that medical card holders already have access to all reimbursable HRT medicines/products, subject to payment of the statutory prescription charge. In addition, many women avail of the Drugs Payment Scheme (DPS) to reduce the cost they pay to access reimbursable HRT products. The current monthly DPS threshold is €80.
The Department and HSE, has engaged extensively with the Irish Pharmacy Union (IPU) in relation to the practical rollout of this measure, which was intended to commence in January.
Last month I met with the IPU to discuss ambitions for expanding and reforming community pharmacy and on progressing the HRT initiative. The IPU committed to coming to back to me regarding the introduction of the HRT scheme. They have done so, and we remain actively engaged on the matter with the goal to introduce this measure as soon as possible.
The HPRA, along with other health service entities, is actively monitoring the national supply, and the current status is that HRT medicines are generally available. There are a number of medicines authorised for use in Ireland as HRT for the treatment of symptoms of menopause. In the event that patients are unable to source a medicinal product due to supply constraints, they are advised to discuss possible alternatives with their healthcare professional pending the resumption of normal supply.
812. Deputy Paul Murphy asked the Minister for Health if she is aware of the case of a child (details supplied); and if she will make a statement on the matter. [13968/25]
Amharc ar fhreagraAs this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
813. Deputy Tom Brabazon asked the Minister for Health if she has visited Beaumont Hospital since her appointment; and, if so, the purpose of each visit, in tabular form. [14000/25]
Amharc ar fhreagraAs Minister for Health I visited Beaumont Hospital briefly on the morning of Tuesday 18thMarch. The purpose of the visit was to meet the staff working in the Emergency Department, to discuss their experience during the St Patrick's Bank Holiday weekend and the progress being made by the hospital on trolley numbers and weekend activity. I have not yet visited Beaumont Hospital on any further occasion as Minister but hope to do so as soon as possible.